SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001144204-17-016590
Filing Date
2017-03-27
Accepted
2017-03-24 18:58:52
Documents
1
Group Members
CHIN KYU HUHILJIN SNT CO., LTD.

Document Format Files

Seq Description Document Type Size
1 SC 13D/A v462405_sc13da.htm SC 13D/A 72239
  Complete submission text file 0001144204-17-016590.txt   73777
Mailing Address #1203-4464 MARKHAM STREET VICTORIA BC A1 V8Z 7X8
Business Address #1203-4464 MARKHAM STREET VICTORIA BC A1 V8Z 7X8 250-708-4272
Aurinia Pharmaceuticals Inc. (Subject) CIK: 0001600620 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A0 | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-88628 | Film No.: 17713848
SIC: 2834 Pharmaceutical Preparations

Mailing Address LVL 15, ILJIN BUILDING DOHWA-DONG, MAPO-GU SEOUL M5 121-716
Business Address LVL 15, ILJIN BUILDING DOHWA-DONG, MAPO-GU SEOUL M5 121-716 00821087787321
ILJIN Life Science Co., Ltd. (Filed by) CIK: 0001633998 (see all company filings)

IRS No.: 000000000
Type: SC 13D/A